immatics biotechnologies GmbH Cash Flow Quality Index
immatics biotechnologies GmbH cash flow quality index. immatics biotechnologies GmbH (4A3) has a Cash Flow Quality Index of -1.21x as of December 2024. Operating cash flow of €-58.48 Million is below net income of €48.39 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial agility of immatics biotechnologies GmbH to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of immatics biotechnologies GmbH (2022–2024)
Cash flow quality index of immatics biotechnologies GmbH from 2022 to 2024. Historical Cash Flow Quality Index for immatics biotechnologies GmbH across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 4A3 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
immatics biotechnologies GmbH Cash Flow Quality Index by Year (2022–2024)
immatics biotechnologies GmbH cash flow quality index by year from 2022 to 2024. Year-by-year earnings quality comparison for immatics biotechnologies GmbH. For the full cash flow conversion analysis, see immatics biotechnologies GmbH cash flow conversion.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -9.63x | €-158.03 Million | €16.41 Million | ▼ -488.3% |
| 2022 | 2.48x | €100.13 Million | €40.38 Million | — |